Open Platform

R&D Technology Platform
  • Therapeutic Monoclonal Antibody and ADC Technology Platform

    The platform has a wide range of functions, including cell cloning screening and cell library construction screening, process development, pilot study and commercial production. Through this platform, we have developed a series of mAb or ADC drugs.

  • Gene Engineering-Based Therapeutics Technology Platform

    The platform integrates anti-tumor immunotherapy, gene therapy and viral therapy, and develops and produces recombinant virus vector system for tumor targets.

  • Innovative Drug Delivery Technology Platform

    We have developed an advanced targeted liposome drug delivery system through this platform. Liposomes are characterized by biocompatibility, biodegradability, low toxicity, embeddable hydrophilic and lipophilic drugs, and drug delivery at specific sites in tumor tissues.